Dublin-based wholesale drug distribution and medical supplies company Cardinal Health is spending $3.9 billion on two ...

Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an ...

The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

Cardinal Health plans acquisitions to anchor its new territory managing specialty physician groups and expand its home-care ...

From energy to healthcare, here's a list of other key deals this week:  Exxon Mobil (NYSE:XOM) has reportedly agreed to ...

Cardinal Health’s planned acquisition of Advanced Diabetes Supply Group for $1.1 billion marries its logistics and ...

The healthcare products and services company plans to acquire Advanced Diabetes Supply Group and a majority stake in GI ...

Cardinal will acquire a majority stake in GIA, a gastroenterology (GI) management services organization (MSO), from a ...

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds.

"GI Alliance joins forces with Cardinal Health to enhance support for physicians" was originally created and published by ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target remains the same with $127.00. Erin Wright has given his ...